{
  "pmid": "39019790",
  "title": "Antibacterial activity of closantel against methicillin-resistant Staphylococcus aureus and itsbiofilm.",
  "abstract": "OBJECTIVES: The antimicrobial resistance of Staphylococcus aureus (S. aureus) has become a challenge in the treatment of infectious diseases. It is of great clinical value to discovery effective antimicrobial agents against multi-drug resistant S. aureus and its biofilms. This study aims to explore the antibacterial activity of the antiparasitic drug closantel against methicillin-resistant S. aureus and its biofilms through drug repurposing. METHODS: The sensitivity of S. aureus to closantel was assessed using microbroth dilution and disk diffusion methods. The bacteriostatic and bactericidal activities of closantel were determined by time-kill curves and colony count. Scanning electron microscopy combined with SYTOX Green and DiSC3(5) fluorescence probes were used to study the bactericidal mechanism of closantel. The influence of resistance was assessed by continuous exposure to sub-inhibitory concentrations of closantel. The anti-biofilm activity was evaluated using 96-well plates and crystal violet staining, and cytotoxicity was measured using the CCK-8 assay. RESULTS: The minimal inhibitory concentration (MIC) of closantel for both methicillin-sensitive and methicillin-resistant S. aureus ranged from 0.125 to 1.000 \u03bcg/mL. Disk diffusion tests showed that 80 \u03bcg of closantel created an inhibition zone, which increased in diameter with higher drug amounts. Sub-inhibitory concentrations (0.031 \u03bcg/mL) of closantel significantly inhibited S. aureus proliferation, reducing bacterial turbidity from 0.26\u00b10.00 to 0.11\u00b10.01 (t=16.06, P<0.001), with stronger inhibition at higher concentrations. Closantel at 0.25\u00d7MIC inhibited S. aureus proliferation for 12 hours, while 1\u00d7MIC inhibited it for over 24 hours, with the number of viable bacteria decreasing as the drug concentration increased. Mechanistic studies indicated that closantel effectively disrupted the integrity of S. aureus cell membranes, significantly increasing SYTOX Green and DiSC3(5) fluorescence intensity. Even after 25 days of continuous exposure to sub-inhibitory concentrations of closantel, no resistance developed. Closantel at 0.0625 \u03bcg/mL significantly inhibited biofilm formation, reducing it from 1.29\u00b10.16 to 0.62\u00b10.04 (t=11.62, P<0.001), showing a clear dose-dependent effect. Closantel at 2 \u03bcg/mL also significantly eradicated established biofilms, reducing biofilm mass from 1.62\u00b10.34 to 0.51\u00b10.39 (t=4.84, P<0.01). Additionally, closantel exhibited extremely low cytotoxicity, with half-maximal lethal concentrations for HepG2 liver cancer cells and normal LO2 liver cells both exceeding 64 \u03bcg/mL. CONCLUSIONS: Closantel exhibits strong antibacterial activity against S. aureus and its biofilm with low cytotoxicity against human cells, making it a promising candidate for new therapeutic strategies against S. aureus-related infections. \u76ee\u7684: \u91d1\u9ec4\u8272\u8461\u8404\u7403\u83cc(\u4ee5\u4e0b\u7b80\u79f0\u201c\u91d1\u8461\u83cc\u201d)\u7684\u8010\u836f\u6027\u5df2\u6210\u4e3a\u611f\u67d3\u6027\u75be\u75c5\u6cbb\u7597\u4e2d\u7684\u96be\u9898\uff0c\u7814\u7a76\u9488\u5bf9\u591a\u91cd\u8010\u836f\u91d1\u8461\u83cc\u53ca\u5176\u751f\u7269\u819c\u7684\u6297\u83cc\u836f\u7269\u5177\u6709\u91cd\u8981\u7684\u4e34\u5e8a\u4ef7\u503c\u3002\u672c\u7814\u7a76\u5c06\u836f\u7269\u91cd\u65b0\u5229\u7528\uff0c\u63a2\u8ba8\u6297\u5bc4\u751f\u866b\u836f\u7269\u6c2f\u6c30\u7898\u67f3\u80fa\u5bf9\u8010\u7532\u6c27\u897f\u6797\u91d1\u8461\u83cc\u53ca\u5176\u751f\u7269\u819c\u7684\u6297\u83cc\u6d3b\u6027\u3002\u65b9\u6cd5: \u901a\u8fc7\u5fae\u91cf\u8089\u6c64\u7a00\u91ca\u5b9e\u9a8c\u548c\u7eb8\u7247\u6269\u6563\u5b9e\u9a8c\u68c0\u6d4b\u91d1\u8461\u83cc\u5bf9\u6c2f\u6c30\u7898\u67f3\u80fa\u7684\u654f\u611f\u6027\u3002\u91c7\u7528\u65f6\u95f4-\u6291\u83cc/\u6740\u83cc\u66f2\u7ebf\u7ed3\u5408\u5e73\u677f\u7a00\u91ca\u83cc\u843d\u8ba1\u6570\u68c0\u6d4b\u6c2f\u6c30\u7898\u67f3\u80fa\u7684\u6291\u83cc\u6548\u7387\u548c\u6740\u83cc\u6d3b\u6027\uff1b\u626b\u63cf\u7535\u955c\u8054\u5408\u8367\u5149\u63a2\u9488SYTOX Green\u548cDiSC3(5)\u7814\u7a76\u6c2f\u6c30\u7898\u67f3\u80fa\u5bf9\u91d1\u8461\u83cc\u7684\u6740\u83cc\u673a\u5236\uff1b\u4e9a\u6291\u83cc\u6d53\u5ea6\u7684\u6c2f\u6c30\u7898\u67f3\u80fa\u8fde\u7eed\u4f5c\u7528\u68c0\u6d4b\u5176\u5bf9\u91d1\u8461\u83cc\u8010\u836f\u7684\u5f71\u54cd\uff1b96\u5b54\u677f\u7ed3\u5408\u7ed3\u6676\u7d2b\u67d3\u8272\u6cd5\u68c0\u6d4b\u6c2f\u6c30\u7898\u67f3\u80fa\u7684\u6297\u751f\u7269\u819c\u6d3b\u6027\uff1bCCK-8\u8bd5\u5242\u76d2\u68c0\u6d4b\u6c2f\u6c30\u7898\u67f3\u80fa\u7684\u7ec6\u80de\u6bd2\u6027\u3002\u7ed3\u679c: \u6c2f\u6c30\u7898\u67f3\u80fa\u5bf9\u7532\u6c27\u897f\u6797\u654f\u611f\u548c\u8010\u836f\u91d1\u8461\u83cc\u7684\u6700\u4f4e\u6291\u83cc\u6d53\u5ea6(minimal inhibitory concentration\uff0cMIC)\u5747\u4e3a0.125~1.000 \u03bcg/mL\u3002\u7eb8\u7247\u6269\u6563\u5b9e\u9a8c\u53d1\u73b080 \u03bcg\u7684\u6c2f\u6c30\u7898\u67f3\u80fa\u5373\u53ef\u51fa\u73b0\u6291\u83cc\u5708\uff0c\u4e14\u968f\u7740\u836f\u91cf\u589e\u52a0\u6291\u83cc\u5708\u76f4\u5f84\u660e\u663e\u589e\u5927\u3002\u4e9a\u6291\u83cc\u6d53\u5ea6(0.031 \u03bcg/mL)\u7684\u6c2f\u6c30\u7898\u67f3\u80fa\u53ef\u663e\u8457\u6291\u5236\u91d1\u8461\u83cc\u7684\u589e\u6b96\uff0c\u4f7f\u7ec6\u83cc\u6d4a\u5ea6\u4ece0.26\u00b10.00\u51cf\u5c11\u52300.11\u00b10.01(t=16.06\uff0cP<0.001)\uff0c\u4e14\u968f\u7740\u6c2f\u6c30\u7898\u67f3\u80fa\u6d53\u5ea6\u7684\u5347\u9ad8\uff0c\u5176\u6291\u83cc\u6d3b\u6027\u8d8a\u5f3a\u30020.25\u00d7MIC\u7684\u6c2f\u6c30\u7898\u67f3\u80fa\u53ef\u6291\u5236\u91d1\u8461\u83cc\u589e\u6b9612 h\uff0c1\u00d7MIC\u7684\u6c2f\u6c30\u7898\u67f3\u80fa\u53ef\u6291\u5236\u91d1\u8461\u83cc\u589e\u6b96\u957f\u8fbe24 h\u4ee5\u4e0a\uff0c\u4e14\u6d3b\u83cc\u6570\u91cf\u968f\u7740\u836f\u7269\u6d53\u5ea6\u5347\u9ad8\u800c\u51cf\u5c11\u3002\u673a\u5236\u7814\u7a76\u7ed3\u679c\u8868\u660e\u6c2f\u6c30\u7898\u67f3\u80fa\u53ef\u6709\u6548\u7834\u574f\u91d1\u8461\u83cc\u7ec6\u80de\u819c\u7684\u5b8c\u6574\u6027\uff0c\u4f7fSYTOX Green\u548cDiSC3(5)\u7684\u8367\u5149\u5f3a\u5ea6\u660e\u663e\u5347\u9ad8\u3002\u5373\u4f7f\u7ecf\u8fc7\u4e9a\u6291\u83cc\u6d53\u5ea6\u6c2f\u6c30\u7898\u67f3\u80fa\u768425 d\u8fde\u7eed\u4f5c\u7528\uff0c\u4ecd\u672a\u4ea7\u751f\u8010\u836f\u6027\u30020.062 5 \u03bcg/mL\u7684\u6c2f\u6c30\u7898\u67f3\u80fa\u5373\u53ef\u663e\u8457\u6291\u5236\u91d1\u8461\u83cc\u751f\u7269\u819c\u7684\u5f62\u6210\uff0c\u4f7f\u5176\u5f62\u6210\u91cf\u4ece1.29\u00b10.16\u51cf\u5c11\u52300.62\u00b10.04(t=11.62\uff0cP<0.001)\uff0c\u4e14\u5448\u73b0\u660e\u663e\u7684\u5242\u91cf\u4f9d\u8d56\u6027\u30022 \u03bcg/mL\u7684\u6c2f\u6c30\u7898\u67f3\u80fa\u8fd8\u53ef\u663e\u8457\u6e05\u9664\u5df2\u5f62\u6210\u7684\u751f\u7269\u819c\uff0c\u4f7f\u751f\u7269\u819c\u91cf\u4ece1.62\u00b10.34\u51cf\u5c11\u52300.51\u00b10.39(t=4.84\uff0cP<0.01)\u3002\u6b64\u5916\uff0c\u6c2f\u6c30\u7898\u67f3\u80fa\u7684\u7ec6\u80de\u6bd2\u6027\u6781\u4f4e\uff0c\u5176\u5bf9\u809d\u764c\u7ec6\u80deHepG2\u548c\u6b63\u5e38\u809d\u810f\u7ec6\u80deLO2\u7684\u534a\u6570\u6291\u5236\u6d53\u5ea6\u5747\u5927\u4e8e64 \u03bcg/mL\u3002\u7ed3\u8bba: \u6c2f\u6c30\u7898\u67f3\u80fa\u5bf9\u91d1\u8461\u83cc\u53ca\u5176\u751f\u7269\u819c\u5177\u6709\u5f3a\u6297\u83cc\u6d3b\u6027\u4e14\u5bf9\u4eba\u4f53\u7ec6\u80de\u6bd2\u6027\u4f4e\uff0c\u6709\u671b\u4e3a\u91d1\u8461\u83cc\u76f8\u5173\u611f\u67d3\u63d0\u4f9b\u65b0\u7684\u6cbb\u7597\u7b56\u7565\u3002. OBJECTIVE: The antimicrobial resistance of Staphylococcus aureus (S. aureus) has become a challenge in the treatment of infectious diseases. It is of great clinical value to discovery effective antimicrobial agents against multi-drug resistant S. aureus and its biofilms. This study aims to explore the antibacterial activity of the antiparasitic drug closantel against methicillin-resistant S. aureus and its biofilms through drug repurposing. METHODS: The sensitivity of S. aureus to closantel was assessed using microbroth dilution and disk diffusion methods. The bacteriostatic and bactericidal activities of closantel were determined by time-kill curves and colony count. Scanning electron microscopy combined with SYTOX Green and DiSC3(5) fluorescence probes were used to study the bactericidal mechanism of closantel. The influence of resistance was assessed by continuous exposure to sub-inhibitory concentrations of closantel. The anti-biofilm activity was evaluated using 96-well plates and crystal violet staining, and cytotoxicity was measured using the CCK-8 assay. RESULTS: The minimal inhibitory concentration (MIC) of closantel for both methicillin-sensitive and methicillin-resistant S. aureus ranged from 0.125 to 1.000 \u03bcg/mL. Disk diffusion tests showed that 80 \u03bcg of closantel created an inhibition zone, which increased in diameter with higher drug amounts. Sub-inhibitory concentrations (0.031 \u03bcg/mL) of closantel significantly inhibited S. aureus proliferation, reducing bacterial turbidity from 0.26\u00b10.00 to 0.11\u00b10.01 (t=16.06, P<0.001), with stronger inhibition at higher concentrations. Closantel at 0.25\u00d7MIC inhibited S. aureus proliferation for 12 hours, while 1\u00d7MIC inhibited it for over 24 hours, with the number of viable bacteria decreasing as the drug concentration increased. Mechanistic studies indicated that closantel effectively disrupted the integrity of S. aureus cell membranes, significantly increasing SYTOX Green and DiSC3(5) fluorescence intensity. Even after 25 days of continuous exposure to sub-inhibitory concentrations of closantel, no resistance developed. Closantel at 0.0625 \u03bcg/mL significantly inhibited biofilm formation, reducing it from 1.29\u00b10.16 to 0.62\u00b10.04 (t=11.62, P<0.001), showing a clear dose-dependent effect. Closantel at 2 \u03bcg/mL also significantly eradicated established biofilms, reducing biofilm mass from 1.62\u00b10.34 to 0.51\u00b10.39 (t=4.84, P<0.01). Additionally, closantel exhibited extremely low cytotoxicity, with half-maximal lethal concentrations for HepG2 liver cancer cells and normal LO2 liver cells both exceeding 64 \u03bcg/mL. CONCLUSION: Closantel exhibits strong antibacterial activity against S. aureus and its biofilm with low cytotoxicity against human cells, making it a promising candidate for new therapeutic strategies against S. aureus-related infections.",
  "journal": "Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences",
  "year": "2024",
  "authors": [
    "Tang H",
    "Zhu Y"
  ],
  "doi": "10.11817/j.issn.1672-7347.2024.230442",
  "mesh_terms": [
    "Biofilms",
    "Methicillin-Resistant Staphylococcus aureus",
    "Anti-Bacterial Agents",
    "Microbial Sensitivity Tests",
    "Salicylanilides"
  ],
  "full_text": "## \u83cc\u682a\u548c\u7ec6\u80de\u6765\u6e90\u53ca\u57f9\u517b\u6761\u4ef6\n\u4ebaHepG2\u7ec6\u80de\u548cLO2\u7ec6\u80de\u682a\u5747\u8d2d\u81ea\u7f8e\u56fd\u83cc\u79cd\u4fdd\u85cf\u4e2d\u5fc3(American Type Culture Collection\uff0cATCC)\u3002\u7532\u6c27\u897f\u6797\u654f\u611f\u91d1\u8461\u83cc(methicillin sensitive Staphylococcus aureus\uff0cMSSA)\u6807\u51c6\u83cc\u682aATCC 25923\u3001MRSA\u6807\u51c6\u83cc\u682aATCC 43300\u548cUSA300\u5747\u8d2d\u81ea\u7f8e\u56fd\u6807\u51c6\u83cc\u682a\u4fdd\u5b58\u4e2d\u5fc3\u3002MRSA(\u5224\u65ad\u6807\u51c6\u4e3a\u5176\u5bf9\u82ef\u5511\u897f\u6797\u7684MIC\u22654 \u03bcg/mL)\u4e34\u5e8a\u83cc\u682aSA1\u3001SA2\u3001SA3\u548cSA4\u5747\u6765\u6e90\u4e8e2022\u5e741\u6708\u81f312\u6708\u957f\u6c99\u5e02\u7b2c\u4e00\u533b\u9662\u80ba\u708e\u4f4f\u9662\u60a3\u8005\u7684\u75f0\u6db2\u6807\u672c\u3002\u6240\u6709\u83cc\u682a\u5747\u63a5\u79cd\u4e8e\u7518\u6cb9\u78c1\u73e0\u4e2d\u5e76\u4e8e-80 \u2103\u4fdd\u5b58\uff0c\u4e8e\u7f8a\u8840\u743c\u8102\u5e73\u677f\u4e0a\u8fde\u7eed\u4f20\u4ee32\u6b21\u540e\u7528\u4e8e\u540e\u7eed\u5b9e\u9a8c\u3002\u9664\u7279\u6b8a\u8bf4\u660e\uff0c\u6240\u6709\u7ec6\u83cc\u57f9\u517b\u57fa\u5747\u4e3aTSB\u3002CST\u548c\u73af\u4e19\u6c99\u661f(ciprofloxacin\uff0cCIP)\u5747\u6eb6\u89e3\u4e8e\u4e8c\u7532\u57fa\u4e9a\u781c(dimethyl sulfoxide\uff0cDMSO)\u4e2d\u4fdd\u5b58\u3002\n\n## \u4e3b\u8981\u4eea\u5668\u548c\u8bd5\u5242\n\u5168\u81ea\u52a8\u9176\u6807\u4eea\u8d2d\u81ea\u7f8e\u56fdBio-Tec\u516c\u53f8\uff1b\u5168\u81ea\u52a8\u9ea6\u6c0f\u6bd4\u6d4a\u4eea\u8d2d\u81ea\u6cd5\u56fdM\u00e9rieux\u516c\u53f8\u3002\u80ce\u725b\u8840\u6e05\u8d2d\u81ea\u4ee5\u8272\u5217BI\u516c\u53f8\uff1bDMEM\u8d2d\u81ea\u5170\u5dde\u5e02\u6c11\u6d77\u751f\u7269\u5de5\u7a0b\u6709\u9650\u516c\u53f8\uff1bRPMI-1640\u8d2d\u81ea\u4e0a\u6d77\u7d22\u83b1\u5b9d\u751f\u7269\u6709\u9650\u516c\u53f8\uff1bCST\u3001VAN\u3001\u8fbe\u6258\u9709\u7d20(daptomycin\uff0cDAP)\u548cCIP\u7c89\u672b\u8d2d\u81ea\u7f8e\u56fdMed Chem Express(MCE)\u516c\u53f8\uff1bSYTOX Green\u548cDiSC3(5)\u8367\u5149\u67d3\u6599\u8d2d\u81ea\u7f8e\u56fdThermo Fisher Scientific\u516c\u53f8\uff1b\u7ed3\u6676\u7d2b\u67d3\u6db2\u8d2d\u81ea\u65e5\u672c\u540c\u4ec1\u5316\u5b66\u7814\u7a76\u6240\uff1b\u80f0\u9176\u5927\u8c46\u8089\u6c64(tryptic soy broth\uff0cTSB)\u548cMH(M\u00fcller-Hinton)\u8089\u6c64\u8d2d\u81ea\u4e0a\u6d77\u7d22\u83b1\u5b9d\u751f\u7269\u6709\u9650\u516c\u53f8\uff1bCCK-8\u8bd5\u5242\u76d2\u8d2d\u81ea\u7f8e\u56fdMCE\u516c\u53f8\uff1bMH\u5e73\u677f\u548c\u7f8a\u8840\u743c\u8102\u5e73\u677f\u8d2d\u81ea\u90d1\u5dde\u5b89\u56fe\u751f\u7269\u6709\u9650\u516c\u53f8\uff1b96\u5b54\u677f\u548c50 mL\u79bb\u5fc3\u7ba1\u8d2d\u81ea\u7f8e\u56fdCorning\u516c\u53f8\u3002\n\n## \u5fae\u91cf\u8089\u6c64\u7a00\u91ca\u5b9e\u9a8c\n\u901a\u8fc7\u5fae\u91cf\u8089\u6c64\u7a00\u91ca\u5b9e\u9a8c\u548c\u7eb8\u7247\u6269\u6563\u5b9e\u9a8c\u68c0\u6d4b\u91d1\u8461\u83cc\u5bf9CST\u7684\u654f\u611f\u6027\u3002\u6311\u53d6\u7f8a\u8840\u743c\u8102\u5e73\u677f\u4e0a\u7684\u5355\u4e2aMRSA\u6216MSSA\u65b0\u9c9c\u83cc\u843d\u4e8e\u65e0\u83cc\u751f\u7406\u76d0\u6c34\u4e2d\uff0c\u7528\u9ea6\u6c0f\u6bd4\u6d4a\u4eea\u8c03\u81f30.5\u9ea6\u6c0f\u6d4a\u5ea6(McFarland\uff0cMcF)\uff0c\u518d\u7528MH\u8089\u6c641\ua789200\u7a00\u91ca\u5907\u7528\u3002\u5c06CST\u3001VAN\u548cDAP\u7528MH\u8089\u6c64\u500d\u6bd4\u7a00\u91ca\u81f3\u7cfb\u5217\u6d53\u5ea60.0313~64 \u03bcg/mL\uff0c\u4e8e96\u5b54\u677f\u4e2d\u6bcf\u5b54\u52a0\u5165 50 \u03bcL\uff0c\u5e76\u5c06\u542b\u6709DMSO\u7684\u5b54\u8bbe\u7f6e\u4e3a\u9634\u6027\u5bf9\u7167\u7ec4\u3002\u6bcf\u5b54\u518d\u5206\u522b\u52a0\u516550 \u03bcL\u5907\u7528\u83cc\u60ac\u6db2\uff0c\u6df7\u5300\u540e\u653e\u7f6e\u4e8e37 \u2103\u6052\u6e29\u57f9\u517b\u7bb1\u4e2d\u9759\u7f6e\u5b75\u80b216~18 h\u3002\u8bfb\u53d6MIC\uff0c\u5373\u4e3a\u6291\u5236\u7ec6\u83cc\u4ea7\u751f\u8089\u773c\u53ef\u89c1\u6d4a\u5ea6\u7684\u6700\u4f4e\u6297\u83cc\u836f\u7269\u6d53\u5ea6[11]\u3002\n\n## Kirby-Bauer(K-B)\u7eb8\u7247\u6269\u6563\u6cd5\u836f\u654f\u5b9e\u9a8c\n\u6311\u53d6\u7f8a\u8840\u743c\u8102\u5e73\u677f\u4e0a\u7684\u5355\u4e2aMRSA\u6216MSSA\u65b0\u9c9c\u83cc\u843d\u4e8e\u65e0\u83cc\u751f\u7406\u76d0\u6c34\u4e2d\uff0c\u7528\u9ea6\u6c0f\u6bd4\u6d4a\u4eea\u8c03\u81f30.5 McF\u3002\u7528\u65e0\u83cc\u68c9\u7b7e\u8638\u53d63\u6b21\u83cc\u60ac\u6db2\u4e8eMH\u5e73\u677f\u4e0a\u5747\u5300\u6d82\u62b9\u3002\u5c06\u5e73\u677f\u9759\u7f6e10 min\u540e\uff0c\u53d65\u7247\u76f4\u5f846 mm\u3001\u539a\u5ea60.7 mm\u7684\u7a7a\u767d\u7eb8\u7247\u5e73\u653e\u5728\u743c\u8102\u8868\u9762\uff0c\u5e76\u4f7f\u7eb8\u7247\u4e4b\u95f4\u7684\u8ddd\u79bb\u8db3\u591f\u5927\uff0c\u518d\u5206\u522b\u70b9\u68372~5 \u03bcL CST\u50a8\u5b58\u6db2 (50 mg/mL)\uff0c\u540c\u65f6\u5c06\u70b9\u68372 \u03bcL\u7684DMSO\u8bbe\u7f6e\u4e3a\u9634\u6027\u5bf9\u7167\u3002\u5c06\u5e73\u677f\u653e\u7f6e\u6e7f\u76d2\u4e2d\uff0c\u4e8e37 \u2103\u9759\u7f6e\u5b75\u80b216~18 h\u540e\uff0c\u62cd\u7167\u8bb0\u5f55[12]\u3002\n\n## \u65f6\u95f4-\u6291\u83cc/\u6740\u83cc\u66f2\u7ebf\n\u91c7\u7528\u65f6\u95f4-\u6291\u83cc/\u6740\u83cc\u66f2\u7ebf\u7ed3\u5408\u5e73\u677f\u7a00\u91ca\u83cc\u843d\u8ba1\u6570\u68c0\u6d4bCST\u7684\u6291\u83cc\u6548\u7387\u548c\u6740\u83cc\u6d3b\u6027\u3002\u6311\u53d6\u7f8a\u8840\u743c\u8102\u5e73\u677f\u4e0aMRSA ATCC 43 300\u7684\u5355\u4e2a\u65b0\u9c9c\u83cc\u843d\u4e8eTSB\u8089\u6c64\u4e2d\uff0c\u4ee537 \u2103\u3001180 r/min\u57f9\u517b\u7ea64 h\u81f3\u5bf9\u6570\u751f\u957f\u671f\u3002\u5c06\u83cc\u60ac\u6db2\u8c03\u81f30.5 McF\uff0c\u7528TSB\u8089\u6c641\ua789200\u7a00\u91ca\uff0c\u52a0\u516510~50 mL\u79bb\u5fc3\u7ba1\u4e2d\u3002\u5206\u522b\u52a0\u5165CST\u4f7fCST\u7684\u7ec8\u6d53\u5ea6\u4e3a0.25\u30010.5\u30011\u30012\u548c4\u00d7MIC(MIC=0.125 \u03bcg/mL)\u3002\u5c06\u52a0\u6709\u76f8\u540c\u4f53\u79ef\u7684DMSO\u8bbe\u7f6e\u4e3a\u9634\u6027\u5bf9\u7167\u7ec4\u3002\u5c06\u79bb\u5fc3\u7ba1\u653e\u7f6e\u4e8e\u6052\u6e29\u6447\u5e8a\u4e0a\uff0c\u4ee537 \u2103\u3001180 r/min\u6447\u83cc\u57f9\u517b\uff0c\u5206\u522b\u57280\u30011\u30012\u30014\u30016\u30018\u300112\u548c24 h\u5438\u53d6100 \u03bcL\u83cc\u60ac\u6db2\u4e8e96\u5b54\u677f\u4e2d\uff0c\u5e76\u7528\u9176\u6807\u4eea\u68c0\u6d4b630 nm\u5904\u7684\u5438\u5149\u5ea6\u503c\uff0c\u5373\u4e3a\u7ec6\u83cc\u7684\u751f\u957f\u6d4a\u5ea6\u3002\u540c\u65f6\uff0c\u5728\u5404\u65f6\u95f4\u70b9\u6bcf\u7ec4\u5206\u522b\u5438\u53d6100 \u03bcL\u83cc\u60ac\u6db2\u7528\u751f\u7406\u76d0\u6c34\u8fdb\u884c\u500d\u6bd4\u7a00\u91ca\u540e\uff0c\u70b9\u6837\u6d82\u5e03\u4e8e\u7f8a\u8840\u743c\u8102\u5e73\u677f\uff0c\u4e8e37 \u2103\u8fc7\u591c\u5b75\u80b2\u540e\uff0c\u8ba1\u7b97\u7ec6\u83cc\u7684\u83cc\u843d\u6570[13]\u3002\n\n## \u626b\u63cf\u7535\u955c\n\u5c06MRSA ATCC 43300\u5728TSB\u8089\u6c64\u4e2d\u57f9\u517b2~4 h\u81f3\u5bf9\u6570\u751f\u957f\u671f\uff0c\u79bb\u5fc38 min\u540e\u53d6\u6c89\u6dc0\u3002\u75281\u00d7PBS(pH=7.4)\u6d17\u6da4\u6c89\u6dc02\u6b21\u540e\uff0c\u52a0\u51651/4\u00d7MIC CST\uff0c37 \u2103\u6447\u83cc\u5b75\u80b21 h\u3002\u53c2\u7167\u6587\u732e[14]\u6b65\u9aa4\u8fdb\u884c\u5904\u7406\uff0c\u901a\u8fc7\u626b\u63cf\u7535\u955c\u89c2\u5bdf\u7ec6\u83cc\u8d85\u5fae\u7ed3\u6784\u3002\n\n## SYTOX Green\u548cDiSC3(5)\u8367\u5149\u63a2\u9488\u68c0\u6d4bCST\u5bf9\u91d1\u8461\u83cc\u7ec6\u80de\u819c\u7684\u5f71\u54cd\nSYTOX Green\u63a2\u9488\u5b9e\u9a8c\uff1a\u5c06\u5bf9\u6570\u76f8\u751f\u957f\u7684MRSA ATCC 43300\u79bb\u5fc38 min\u540e\u53d6\u6c89\u6dc0\uff0c\u5e76\u75285 mmol/L HEPES(pH=7.2)\u6f02\u6d17\u6c89\u79ef\u72693\u6b21\uff0c\u91cd\u60ac\u81f3OD630=0.2\u3002\u5c062 \u00b5mol/L\u7684SYTOX Green\u4e0e\u83cc\u60ac\u6db2\u907f\u5149\u5b75\u80b215 min\u540e\uff0c\u52a0\u5165\u7528PBS\u500d\u6bd4\u7a00\u91ca\u7684\u542b\u6709CST(1/4\u00d7MIC~1\u00d7MIC)\u7684\u9ed1\u827296\u5b54\u677f\u4e2d\u3002\u7528\u5168\u81ea\u52a8\u8367\u5149\u9176\u6807\u4eea\u68c0\u6d4b\u6fc0\u53d1\u6ce2\u957f\u548c\u53d1\u5c04\u6ce2\u957f\u5206\u522b\u4e3a485 nm\u548c525 nm\u7684\u8367\u5149\u5f3a\u5ea6\uff0c\u6bcf5 min\u6d4b\u91cf1\u6b21\uff0c\u6301\u7eed10 min\u3002DMSO\u5904\u7406\u7ec4\u8bbe\u7f6e\u4e3a\u5bf9\u7167\u7ec4\u3002\nDiSC3(5)\u63a2\u9488\u5b9e\u9a8c\uff1a\u5982\u4e0a\u6240\u8ff0\u5236\u5907\u91d1\u8461\u83cc\u60ac\u6d6e\u6db2\uff0c\u6240\u7528\u7684HEPES\u7f13\u51b2\u6db2\u5305\u542b5 mmol/L\u8461\u8404\u7cd6\u548c 100 mmol/L KCl\u3002\u5c062 \u00b5mol/L\u7684DiSC3(5)\u4e0e\u83cc\u60ac\u6db2\u907f\u5149\u5b75\u80b245 min\u540e\uff0c\u52a0\u5165\u7528PBS\u500d\u6bd4\u7a00\u91ca\u7684\u542b\u6709CST(1/4~1\u00d7MIC)\u7684\u9ed1\u827296\u5b54\u677f\u4e2d\u3002\u68c0\u6d4b\u6fc0\u53d1\u6ce2\u957f\u548c\u53d1\u5c04\u6ce2\u957f\u5206\u522b\u4e3a622 nm\u548c670 nm\u7684\u8367\u5149\u5f3a\u5ea6\uff0c\u6bcf30 s\u6d4b\u91cf1\u6b21\uff0c\u6301\u7eed10 min\u3002DMSO\u5904\u7406\u7ec4\u8bbe\u7f6e\u4e3a\u5bf9\u7167\u7ec4[15]\u3002\n\n## \u8010\u836f\u7b5b\u9009\u5b9e\u9a8c\n\u7b2c1\u5929\uff0c\u901a\u8fc7\u5982\u4e0a\u6240\u8ff0\u7684\u5fae\u91cf\u8089\u6c64\u7a00\u91ca\u5b9e\u9a8c\u5206\u522b\u68c0\u6d4bCIP\u548cCST\u5bf9MRSA\u7684MIC(\u6d4b\u5f97CIP\u5bf9ATCC 43300\u548cUSA300\u7684MIC\u5206\u522b\u4e3a1\u548c32 \u03bcg/mL\uff1bCST\u5bf9MRSA ATCC 43300\u548cUSA300\u7684MIC\u5206\u522b\u4e3a0.125\u548c1 \u03bcg/mL)\u3002\u6b21\u65e5\uff0c\u5c06\u4e9a\u6291\u83cc\u6d53\u5ea6(0.5\u00d7MIC)\u5b54\u4e2d\u7684\u83cc\u60ac\u6db2\u7a00\u91ca1 000\u500d\u540e\uff0c\u7ee7\u7eed\u8fdb\u884c\u5fae\u91cf\u8089\u6c64\u7a00\u91ca\u5b9e\u9a8c\u300237 \u2103\u9759\u7f6e\u5b75\u80b224 h\u540e\uff0c\u5c060.5\u00d7MIC\u5b54\u4e2d\u7684\u83cc\u60ac\u6db2\u7a00\u91ca1 000\u500d\u8fdb\u884c\u540e\u7eed\u5fae\u91cf\u8089\u6c64\u7a00\u91ca\u5b9e\u9a8c\u3002\u5171\u8fde\u7eed\u68c0\u6d4b25 d\uff0c\u8bb0\u5f55\u6bcf\u65e5MIC\u503c[7]\u3002\n\n## \u751f\u7269\u819c\u6291\u5236\u5b9e\u9a8c\n\u6311\u53d6\u7f8a\u8840\u743c\u8102\u5e73\u677f\u4e0a\u7684\u5355\u4e2a\u65b0\u9c9c\u83cc\u843d\u4e8eTSB\u8089\u6c64\u4e2d\uff0c\u4ee537 \u2103\u3001180 r/min\u57f9\u517b24 h\u3002\u7528TSB\u5c06\u83cc\u60ac\u6db21\ua789100\u7a00\u91ca\u540e\uff0c\u4e8e96\u5b54\u677f\u4e2d\u6bcf\u5b54\u52a0100 \u03bcL\u5907\u7528\u3002\u5c06CST\u7528TSB\u500d\u6bd4\u7a00\u91ca\u540e(0.062 5~1 \u03bcg/mL)\uff0c\u5206\u522b\u52a0\u5165100 \u03bcL\u81f3\u5907\u7528\u83cc\u60ac\u6db2\u4e2d\u3002\u5c0696\u5b54\u677f\u653e\u7f6e\u4e8e\u6e7f\u76d2\u4e2d\uff0c\u4e8e37 \u2103\u9759\u7f6e\u5b75\u80b224 h\u3002\u5f03\u4e0a\u6e05\uff0c\u7528\u751f\u7406\u76d0\u6c34\u8f7b\u6d173\u6b21\uff0c\u6bcf\u5b54\u5206\u522b\u52a0\u5165200 \u03bcL 0.25%\u7ed3\u6676\u7d2b\u67d3\u6db2\u3002\u9759\u7f6e\u5b75\u80b210 min\u540e\uff0c\u5f03\u7ed3\u6676\u7d2b\uff0c\u7528\u751f\u7406\u76d0\u6c34\u7ee7\u7eed\u8f7b\u6d173\u6b21\u4ee5\u53bb\u9664\u672a\u4e0e\u751f\u7269\u819c\u7ed3\u5408\u7684\u7ed3\u6676\u7d2b\uff0c\u5f03\u4e0a\u6e05\u540e\u4e8e\u9176\u6807\u4eea\u68c0\u6d4b570 nm\u5904\u7684\u5438\u5149\u5ea6\u503c\uff0c\u5373\u4e3a\u751f\u7269\u819c\u7684\u603b\u91cf[16]\u3002\n\n## \u751f\u7269\u819c\u6e05\u9664\u5b9e\u9a8c\n\u5c06\u57f9\u517b24 h\u7684\u83cc\u60ac\u6db21\ua789200\u7a00\u91ca\u540e\uff0c\u4e8e96\u5b54\u677f\u4e2d\u6bcf\u5b54\u52a0\u5165200 \u03bcL\u3002\u4e8e\u6052\u6e29\u57f9\u517b\u7bb1\u4e2d37 \u2103\u9759\u7f6e\u5b75\u80b2 24 h\u4ee5\u6784\u5efa\u751f\u7269\u819c\u3002\u5f03\u4e0a\u6e05\uff0c\u7528\u751f\u7406\u76d0\u6c34\u8f7b\u6d17\u53bb\u9664\u672a\u4e0e96\u5b54\u677f\u7ed3\u5408\u7684\u7ec6\u83cc\u540e\uff0c\u5f03\u4e0a\u6e05\u3002\u5c06CST\u7528TSB\u500d\u6bd4\u7a00\u91ca\u540e(1~16 \u03bcg/mL)\uff0c\u6bcf\u5b54\u5206\u522b\u52a0\u5165200 \u03bcL\u3002\u4e8e37 \u2103\u9759\u7f6e\u5b75\u80b224 h\u540e\uff0c\u5f03\u4e0a\u6e05\uff0c\u7528\u751f\u7406\u76d0\u6c34\u8f7b\u6d173\u6b21\u53bb\u9664\u672a\u4e0e\u5b54\u5e95\u7ed3\u5408\u7684\u7ec6\u83cc\u3002\u968f\u540e\u8fdb\u884c\u7ed3\u6676\u7d2b\u67d3\u8272\uff0c\u6b65\u9aa4\u540c\u4e0a[17]\u3002\n\n## CCK-8\u68c0\u6d4b\u6297\u83cc\u836f\u7269\u7684\u7ec6\u80de\u6bd2\u6027\nHepG2\u7ec6\u80de\u57f9\u517b\u4e8e\u542b10%\u80ce\u725b\u8840\u6e05+1%\u53cc\u6297(\u9752\u9709\u7d20+\u94fe\u9709\u7d20)\u7684DMEM\u57f9\u517b\u57fa\u4e2d\uff0cLO2\u7ec6\u80de\u57f9\u517b\u4e8e\u542b10%\u80ce\u725b\u8840\u6e05+1%\u53cc\u6297\u7684RPMI-1640\u57f9\u517b\u57fa\u4e2d\u3002\u5c06\u7ec6\u80de\u7f6e\u4e8e37 \u2103\u30015% CO2\u7684\u9971\u548c\u6e7f\u5ea6\u57f9\u517b\u7bb1\u4e2d\u57f9\u517b\u3002\u53d6\u5bf9\u6570\u751f\u957f\u76845\u00d7103\u4e2a\u7ec6\u80de\u94fa\u677f\u572896\u5b54\u677f\u4e2d\uff0c\u5f85\u7ec6\u80de\u8d34\u58c1\u540e\u6bcf\u5b54\u52a0\u5165100 \u03bcL\u542b\u6709DMEM\u6216RPMI-1640\u57f9\u517b\u57fa\u500d\u6bd4\u7a00\u91ca\u7684CST(4~64 \u03bcg/mL)\u3002\u4ee537 \u2103\u30015%CO2\u5b75\u80b224 h\u540e\uff0c\u53bb\u4e0a\u6e05\uff0c\u6bcf\u5b54\u52a0\u5165100 \u03bcL\u542b\u6709CCK-8\u7684\u57f9\u517b\u57fa\u3002\u4ee537 \u2103\u30015% CO2\u7ee7\u7eed\u5b75\u80b24 h\u540e\u4e8e\u9176\u6807\u4eea\u68c0\u6d4b450 nm\u5904\u7684\u5438\u5149\u5ea6\u503c[18]\u3002\n\n## \u7edf\u8ba1\u5b66\u5904\u7406\n\u91c7\u7528Graphpad Prism 8.0\u8f6f\u4ef6\u8fdb\u884c\u6570\u636e\u5206\u6790\u3002\u8ba1\u91cf\u8d44\u6599\u7528\u5747\u6570\u00b1\u6807\u51c6\u5dee\u8868\u793a\uff0c\u91c7\u7528Shapiro-Wilk\u6cd5\u68c0\u9a8c\u6570\u636e\u7684\u6b63\u6001\u6027\uff0c2\u7ec4\u6bd4\u8f83\u91c7\u7528\u53cc\u4fa7\u975e\u914d\u5bf9t\u68c0\u9a8c\uff0c\u591a\u7ec4\u6bd4\u8f83\u91c7\u7528\u5355\u56e0\u7d20\u65b9\u5dee\u5206\u6790\u3002P<0.05\u4e3a\u5dee\u5f02\u6709\u7edf\u8ba1\u5b66\u610f\u4e49\u3002\n\n## \n\nCST\u7684\u7ed3\u6784\u5f0f\u4e3aN-[5-\u6c2f-4-(4-\u6c2f-\u03b1-\u6c30\u57fa\u82c4\u57fa)-2-\u7532\u57fa\u82ef\u57fa]-2-\u7f9f\u57fa-3,5-\u4e8c\u7898\u4ee3\u82ef\u7532\u9170\u80fa\uff0c\u5176\u4e2d\u5305\u542b1\u4e2a\u6c30\u57fa\u548c4\u4e2a\u5364\u4ee3\u70c3(\u56fe1A)\u3002\u91d1\u8461\u83cc\u5bf9CST\u5177\u6709\u6781\u9ad8\u7684\u654f\u611f\u6027\uff0c\u5bf9MSSA\u548cMRSA\u6807\u51c6\u83cc\u682a\u7684MIC\u4ec5\u4e3a0.25~1.00 \u03bcg/mL\uff0c\u4e14\u5bf9\u5176\u4e34\u5e8a\u83cc\u682a\u4e5f\u5177\u6709\u76f8\u540c\u7684\u654f\u611f\u6027(\u88681)\u3002K-B\u7eb8\u7247\u6cd5\u548c\u6d53\u5ea6-\u6291\u83cc\u66f2\u7ebf\u7ed3\u679c\u663e\u793a\uff1aCST\u7684\u6291\u83cc\u5708\u968f\u7740\u836f\u7269\u542b\u91cf\u7684\u589e\u591a\u800c\u53d8\u5927\uff0c\u5176\u6291\u83cc\u6d3b\u6027\u4e5f\u968f\u7740\u836f\u7269\u6d53\u5ea6\u7684\u5347\u9ad8\u800c\u589e\u52a0(\u56fe1B\u548c1C)\u3002CST\u8fd8\u5177\u6709\u957f\u65f6\u7a0b\u7684\u6291\u83cc\u6548\u679c\uff0c1\u00d7MIC\u7684CST\u53ef\u6301\u7eed 24 h\u6291\u83cc\u7ec6\u83cc\u589e\u6b96\u3002\u5373\u4f7f0.5\u00d7MIC\u7684CST\u4f5c\u752824 h\u4e5f\u53ef\u6291\u5236\u6291\u83cc\u6d4a\u5ea6\u7684\u5347\u9ad8(\u56fe1D)\u3002\u6b64\u5916\uff0c\u901a\u8fc7\u5e73\u677f\u7a00\u91ca\u83cc\u843d\u8ba1\u6570\uff0c\u53d1\u73b00.5\u00d7MIC\u7684CST\u80fd\u6709\u6548\u964d\u4f4e\u6d3b\u83cc\u6570\u91cf\uff0c\u4e14\u968f\u7740CST\u6d53\u5ea6\u7684\u5347\u9ad8\uff0c\u91d1\u8461\u83cc\u6d3b\u83cc\u91cf\u660e\u663e\u964d\u4f4e\uff0c\u5177\u6709\u663e\u8457\u7684\u6d53\u5ea6\u4f9d\u8d56\u6027(\u56fe1E)\u3002\n\n## \n\n\u626b\u63cf\u7535\u955c\u89c2\u5bdfCST\u5904\u7406\u540e\u7684\u91d1\u8461\u83cc\u7ec6\u80de\u5f62\u6001\uff0c\u53d1\u73b01/4\u00d7MIC\u7684CST\u5904\u7406\u91d1\u8461\u83cc1 h\u5373\u53ef\u4f7f\u5176\u7ec6\u80de\u819c\u660e\u663e\u51f9\u9677\uff0c\u7ec6\u80de\u5f62\u6001\u76b1\u7f29\u5d29\u584c\uff0c\u521d\u6b65\u63a8\u6d4bCST\u53ef\u7834\u574f\u91d1\u8461\u83cc\u7684\u7ec6\u80de\u819c(\u56fe2A)\u3002\u7ec6\u80de\u819c\u6e17\u900f\u7279\u5f02\u6027\u8367\u5149\u63a2\u9488SYTOX Green\u5b9e\u9a8c\u7ed3\u679c\u663e\u793a\uff1a\u4e0e\u672a\u52a0\u836f\u7684\u5bf9\u7167\u7ec4\u76f8\u6bd4\uff0c1/4\u00d7MIC\u7684CST\u53ef\u5347\u9ad8SYTOX Green\u7684\u8367\u5149\u5f3a\u5ea6\uff0c\u4e14\u968f\u7740CST\u6d53\u5ea6\u7684\u5347\u9ad8\uff0c\u5176\u8367\u5149\u5f3a\u5ea6\u660e\u663e\u4e0a\u5347(\u56fe2B)\u3002\u8fdb\u4e00\u6b65\u7684\u819c\u7535\u4f4d\u7279\u5f02\u6027\u8367\u5149\u63a2\u9488DiSC3(5)\u5b9e\u9a8c\u53d1\u73b0\uff1a1/4\u00d7MIC\u7684CST\u5728\u4e00\u5b9a\u7a0b\u5ea6\u4e0a\u5347\u9ad8DiSC3(5)\u7684\u8367\u5149\u5f3a\u5ea6\uff0c\u4e14\u968f\u7740CST\u6d53\u5ea6\u589e\u52a0\uff0c\u5176\u8367\u5149\u5f3a\u5ea6\u4e0a\u5347\u660e\u663e\uff0c\u5177\u6709\u6d53\u5ea6\u4f9d\u8d56\u6027(\u56fe2C)\u3002\n\n## \n\n\u4e9a\u6291\u83cc\u6d53\u5ea6\u6297\u83cc\u836f\u7269\u8fde\u7eed\u4f20\u4ee3\u5b9e\u9a8c\u7ed3\u679c\u8868\u660e\uff1a0.5\u00d7MIC\u7684CIP\u8fde\u7eed\u4f5c\u752825 d\u540e\uff0c\u53ef\u4f7fMRSA\u6807\u51c6\u83cc\u682aATCC 43300\u548cUSA300\u51fa\u73b0\u8010\u836f\u682a\uff0c\u5176MIC\u5206\u522b\u5347\u9ad8\u81f3\u539f\u4ee3\u768432\u500d\u548c64\u500d\uff1b\u800c0.5\u00d7MIC\u7684CST\u5373\u4f7f\u8fde\u7eed\u4f20\u4ee325 d\uff0c\u4e5f\u672a\u89c1\u8010\u836f\u682a\u7684\u4ea7\u751f\uff0c\u5176\u654f\u611f\u6027\u4ecd\u7136\u7b49\u540c\u4e8e\u539f\u4ee3\u7ec6\u83cc\uff0cMIC\u65e0\u660e\u663e\u6539\u53d8(\u56fe3)\u3002\n\n## \n\n\u7ed3\u6676\u7d2b\u67d3\u8272\u7ed3\u679c\u8868\u660eCST\u5bf9MRSA ATCC 43300\u663e\u793a\u51fa\u663e\u8457\u7684\u751f\u7269\u819c\u5f62\u6210\u6291\u5236\u6d3b\u6027\u30020.0625 \u03bcg/mL\u7684CST\u5373\u53ef\u663e\u8457\u6291\u5236\u5176\u751f\u7269\u819c\u7684\u5f62\u6210\uff0c\u4f7f\u751f\u7269\u819c\u7684\u5f62\u6210\u91cf\u4ece1.29\u00b10.16\u51cf\u5c110.62\u00b10.04(t=11.62\uff0cP<0.001)\uff1b\u4e14\u968f\u7740\u6d53\u5ea6\u7684\u589e\u52a0\uff0c\u5176\u751f\u7269\u819c\u6291\u5236\u6d3b\u6027\u660e\u663e\u589e\u5f3a(\u56fe4A)\u30022~16 \u03bcg/mL\u7684CST\u8fd8\u80fd\u6709\u6548\u6e05\u9664\u5df2\u5f62\u6210\u7684\u751f\u7269\u819c\uff0c2 \u03bcg/mL\u7684CST\u53ef\u4f7f\u5df2\u5f62\u6210\u751f\u7269\u819c\u7684\u603b\u91cf\u4ece1.62\u00b10.34\u51cf\u5c11\u52300.51\u00b10.39(t=4.84\uff0cP<0.01\uff1b\u56fe4B)\u30020.25 \u03bcg/mL\u7684CST\u80fd\u663e\u8457\u6291\u5236MRSA\u4e34\u5e8a\u83cc\u682a\u751f\u7269\u819c\u7684\u5f62\u6210\uff0c\u4f7fSA1\u3001SA2\u3001SA3\u548cSA4\u7684\u751f\u7269\u819c\u5f62\u6210\u91cf\u5206\u522b\u4ece1.63\u00b10.09\u30012.26\u00b10.02\u30010.87\u00b10.04\u548c1.68\u00b10.02\u51cf\u5c11\u52300.51\u00b10.01\u30010.87\u00b10.06\u30010.33\u00b10.03\u548c0.37\u00b10.06(\u5747P<0.001\uff0c\u56fe5A)\u3002\u540c\u65f6\uff0c2 \u03bcg/mL\u7684CST\u4e5f\u53ef\u663e\u8457\u6e05\u9664MRSA\u4e34\u5e8a\u83cc\u682a\u5df2\u5f62\u6210\u7684\u751f\u7269\u819c\uff0c\u4f7f\u5176\u751f\u7269\u819c\u7684\u603b\u91cf\u4ece2.51\u00b10.08\u30012.65\u00b10.07\u30011.32\u00b10.03\u548c2.44\u00b10.06\u964d\u4f4e\u52300.88\u00b10.05\u30011.27\u00b10.07\u30010.72\u00b10.09\u548c0.73\u00b10.07(\u5747P<0.001\uff0c\u56fe5B)\u3002\n\n## \n\nCCK-8\u5b9e\u9a8c\u7ed3\u679c\u8868\u660eCST\u7684\u7ec6\u80de\u6bd2\u6027\u6781\u4f4e\u3002CST\u7684\u6d53\u5ea6\u5373\u4f7f\u9ad8\u8fbe62 \u03bcg/mL\uff0c\u5bf9\u6b63\u5e38\u809d\u6765\u6e90\u7ec6\u80deLO2(\u56fe6A)\u548c\u809d\u80bf\u7624\u7ec6\u80deHepG2(\u56fe6B)\u4e5f\u65e0\u660e\u663e\u7684\u7ec6\u80de\u6bd2\u6027\uff0c\u5176\u534a\u6570\u6291\u5236\u6d53\u5ea6(half maximal inhibitory concentration\uff0cIC50)\u5747\u5927\u4e8e64 \u03bcg/mL\u3002\n\n## \u8ba8 \u8bba\nMRSA\u53ca\u5176\u751f\u7269\u819c\u7684\u5f62\u6210\u7ed9\u4e34\u5e8a\u8bca\u7597\u5e26\u6765\u6781\u5927\u7684\u56f0\u96be\uff0c\u65b0\u578b\u6297\u83cc\u836f\u7269\u7684\u7814\u53d1\u5df2\u6210\u4e3a\u4e9f\u5f85\u89e3\u51b3\u7684\u96be\u9898\u3002\u672c\u7814\u7a76\u901a\u8fc7\u8001\u836f\u65b0\u7528\uff0c\u53d1\u73b0\u6297\u5bc4\u751f\u866b\u836f\u7269CST\u5bf9MRSA\u6807\u51c6\u83cc\u682a\u548c\u4e34\u5e8a\u5206\u79bb\u83cc\u682a\u5747\u5177\u6709\u6709\u6548\u7684\u6297\u83cc\u6d3b\u6027\u4e14\u5176\u8010\u836f\u682a\u4ea7\u751f\u7684\u80fd\u529b\u6781\u4f4e\u3002\u6b64\u5916\uff0cCST\u8fd8\u80fd\u663e\u8457\u6291\u5236MRSA\u751f\u7269\u819c\u7684\u5f62\u6210\u5e76\u80fd\u6e05\u9664\u5df2\u5f62\u6210\u7684\u751f\u7269\u819c\u3002CST\u7684\u5f3a\u6297\u83cc\u6d3b\u6027\u548c\u4f4e\u7ec6\u80de\u6bd2\u6027\u4f7f\u5176\u6709\u6f5c\u529b\u7814\u53d1\u6210\u4e3a\u6297\u83cc\u836f\u7269\u6cbb\u7597\u96be\u6cbb\u6027\u91d1\u8461\u83cc\u76f8\u5173\u611f\u67d3\u3002\n\u8001\u836f\u65b0\u7528\u5177\u6709\u4f20\u7edf\u6297\u83cc\u836f\u7269\u7814\u53d1\u4e0d\u53ef\u53d6\u4ee3\u7684\u4f18\u70b9\u3002\u4e0e\u65b0\u836f\u7814\u53d1\u76f8\u6bd4\uff0c\u8001\u836f\u65b0\u7528\u5177\u6709\u66f4\u4f4e\u7684\u603b\u4f53\u5f00\u53d1\u6210\u672c\u3001\u66f4\u77ed\u7684\u7814\u53d1\u65f6\u95f4\u548c\u6781\u4f4e\u7684\u5b89\u5168\u98ce\u9669[19]\u3002\u672c\u7814\u7a76\u4e2d\uff0cCST\u5bf9MRSA\u7684\u6297\u83cc\u6d3b\u6027\u6781\u9ad8\uff0c\u5176MIC\u4ec5\u4e3a0.125~1.000 \u03bcg/mL\u3002\u8fd1\u5e74\u6765\uff0c\u901a\u8fc7\u8001\u836f\u65b0\u7528\uff0c\u7814\u7a76\u8005\u53d1\u73b0\u4e86\u4e00\u4e9b\u6781\u5177\u6f5c\u529b\u7684\u6297\u83cc\u836f\u7269\u3002\u5982\u7c7b\u89c6\u9ec4\u9187\u7c7b\u6297\u80bf\u7624\u836f\u7269CD437\u548cCD1530\u6709\u663e\u8457\u7684\u6297\u91d1\u8461\u83cc\u6d3b\u6027\uff0c\u4f46\u5176MIC\u4ecd\u67091~2 \u03bcg/mL\uff0c\u76f8\u6bd4\u4e4b\u4e0bCST\u7684\u6297\u83cc\u6d3b\u6027\u66f4\u4f73\uff1b\u6b64\u5916\uff0c3~5 \u03bcg/mL\u7684CD437\u548cCD1530\u5bf9\u809d\u80bf\u7624\u7ec6\u80deHepG2\u663e\u793a\u51fa\u663e\u8457\u7684\u7ec6\u80de\u6bd2\u6027\uff0c\u5f53\u5176\u6d53\u5ea6\u8fbe\u523020 \u03bcg/mL\u65f6\uff0c\u5bf9\u6b63\u5e38\u809d\u810f\u7ec6\u80deLO2\u4e5f\u6709\u660e\u663e\u7684\u7ec6\u80de\u6bd2\u6027[7]\u3002\u56e0\u6b64\uff0cCST\u7684\u809d\u7ec6\u80de\u6bd2\u6027\u6bd4CD437\u548cCD1530\u66f4\u4f4e\u3002Bithionol\u662f\u4e00\u79cd\u6297\u5bc4\u751f\u866b\u836f\u7269\uff0cKim\u7b49[20]\u53d1\u73b0\u5176\u5177\u6709\u6709\u6548\u7684\u6297\u91d1\u8461\u83cc\u6d3b\u6027\uff0c\u5176MIC\u4e3a0.5~2.0 \u03bcg/mL\u3002\u800c\u672c\u7814\u7a76\u4e2d\u7684CST\u7684MIC\u603b\u4f53\u6bd4Bithionol\u66f4\u4f4e\u3002\u6b64\u5916\uff0c\u8fd1\u5e74\u6765\u901a\u8fc7\u8001\u836f\u65b0\u7528\u65b0\u53d1\u73b0\u7684\u6297\u83cc\u836f\u7269\u91d1\u8bfa\u82ac[21]\u3001\u53f8\u62c9\u514b\u4e01[22]\u3001\u7532\u8418\u918c[23]\u7b49\uff0c\u56e0\u5176\u7ec6\u80de\u6bd2\u6027\u3001\u4f53\u5185\u4ee3\u8c22\u52a8\u529b\u5b66\u7f3a\u9677\u548c\u7a33\u5b9a\u6027\u7b49\u56e0\u7d20\u8fd8\u505c\u6ede\u4e8e\u5b9e\u9a8c\u9636\u6bb5\u3002\u800cCST\u4e0d\u4ec5\u5177\u6709\u6781\u5f3a\u7684\u6297\u83cc\u6d3b\u6027\uff0c\u5176\u7ec6\u80de\u6bd2\u6027\u4e5f\u6781\u4f4e\uff0c\u5b89\u5168\u7cfb\u6570\u9ad8\uff0c\u6210\u836f\u6f5c\u529b\u5927\u3002\n\u91d1\u8461\u83cc\u5177\u6709\u5f3a\u5927\u7684\u9002\u5e94\u5404\u79cd\u4e0d\u5229\u73af\u5883\u6761\u4ef6\u7684\u80fd\u529b\uff0c\u5e76\u5177\u6709\u5bf9\u51e0\u4e4e\u6240\u6709\u6297\u751f\u7d20\u4ea7\u751f\u8010\u836f\u7684\u80fd\u529b\u3002\u91d1\u8461\u83cc\u4ea7\u751f\u7684\u8fd9\u4e9b\u8010\u836f\u6027\u901a\u5e38\u4f1a\u7ed9\u5bbf\u4e3b\u5e26\u6765\u4e25\u91cd\u7684\u5065\u5eb7\u8d1f\u62c5\u3002\u8fd9\u4e9b\u8010\u836f\u6027\u7684\u4ea7\u751f\u5f80\u5f80\u662f\u901a\u8fc7\u7ec6\u83cc\u81ea\u8eab\u57fa\u56e0\u7ec4\u7684\u7a81\u53d8\u548c\u91cd\u6392\uff0c\u6216\u8005\u901a\u8fc7\u8010\u836f\u57fa\u56e0\u6c34\u5e73\u4f20\u64ad\u800c\u4ea7\u751f\u3002\u4e00\u65b9\u9762\uff0c\u91d1\u8461\u83cc\u53ef\u4ee5\u901a\u8fc7\u7279\u6b8a\u7684\u6297\u751f\u7d20\u8bc6\u522b\u4fe1\u53f7\u8f6c\u6362\u5668\u4ecb\u5bfc\u7ec6\u83cc\u8010\u836f\u6027\u7684\u4ea7\u751f\uff1b\u53e6\u4e00\u65b9\u9762\uff0c\u6297\u751f\u7d20\u8010\u836f\u8868\u578b\u7684\u4ea7\u751f\u4e5f\u53ef\u80fd\u662f\u7531\u83cc\u682a\u7684\u9057\u4f20\u80cc\u666f\u548c\u67d0\u4e9b\u73af\u5883\u56e0\u7d20\u5171\u540c\u4f5c\u7528\u3002\u4f8b\u5982\u8010\u836f\u6027\u7684\u95f4\u63a5\u8c03\u8282\u53ef\u4ee5\u901a\u8fc7\u6539\u53d8\u6297\u6027\u57fa\u56e0\u7684\u8868\u8fbe\u6216\u5e95\u7269\u7ed3\u5408\u7684\u7279\u5f02\u6027\u6765\u4ea7\u751f\uff1b\u6b64\u5916\uff0c\u67d0\u4e9b\u63d2\u5165\u5143\u4ef6\u53ef\u4ee5\u901a\u8fc7\u6253\u5f00\u6216\u5173\u95ed\u76f8\u5173\u57fa\u56e0\u7684\u8868\u8fbe\u6765\u6539\u53d8\u5bf9\u6297\u751f\u7d20\u7684\u8010\u836f\u6027[24]\u3002\u7ec6\u83cc\u7ec6\u80de\u819c\u548cDNA\u7684\u635f\u4f24\u5bfc\u81f4\u7684\u6025\u6027\u5e94\u6fc0\u53cd\u5e94\u6216\u4e2d\u95f4\u4ee3\u8c22\u7f3a\u9677\u5f15\u53d1\u7684\u53cd\u5e94\u4e5f\u4f1a\u5bf9\u6297\u6027\u7684\u53d1\u5c55\u4ea7\u751f\u5f71\u54cd\u3002\u4e34\u5e8a\u4e0a\uff0c\u91d1\u8461\u83cc\u7684\u8010\u836f\u6027\u901a\u5e38\u662f\u591a\u4e2a\u6b65\u9aa4\u5171\u540c\u5bfc\u81f4\u7684\u3002\u672c\u7814\u7a76\u53d1\u73b0\u4e9a\u6291\u83cc\u6d53\u5ea6\u7684CST\u5373\u4f7f\u4f5c\u7528\u4e8e\u91d1\u8461\u83cc20 d\u4ecd\u672a\u53d1\u73b0\u8010\u836f\u6027\u7684\u4ea7\u751f\u3002\u8fd9\u53ef\u80fd\u4e0e\u5176\u9776\u5411\u7ec6\u80de\u819c\u7684\u4f5c\u7528\u673a\u5236\u76f8\u5173\uff0c\u56e0\u4e3a\u7ec6\u80de\u819c\u7531\u78f7\u8102\u5206\u5b50\u6784\u6210\uff0c\u6781\u5c11\u53d1\u751f\u53d8\u5f02\uff0c\u6240\u4ee5CST\u6781\u96be\u51fa\u73b0\u7ec6\u83cc\u8010\u836f\u6027\u3002\n\u751f\u7269\u819c\u4e3b\u8981\u7531\u7ec6\u83cc\u83cc\u4f53\u3001\u80de\u5916\u591a\u7cd6\u3001\u80de\u5916DNA\u548c\u80de\u5916\u86cb\u767d\u8d28\u7b49\u6210\u5206\u6784\u6210\u3002\u751f\u7269\u819c\u7684\u751f\u7406\u5468\u671f\u4e3b\u8981\u5305\u62ec4\u4e2a\u6b65\u9aa4\uff1a\u521d\u59cb\u9ecf\u9644\u671f\u3001\u751f\u7269\u819c\u5f62\u6210\u521d\u671f\u3001\u751f\u7269\u819c\u6210\u719f\u671f\u548c\u5206\u6563\u671f[25]\u3002\u91d1\u8461\u83cc\u751f\u7269\u819c\u7684\u5f62\u6210\u548c\u5206\u6563\u8fc7\u7a0b\u53d7\u5230\u591a\u4e2a\u8c03\u63a7\u7cfb\u7edf\u7684\u5171\u540c\u5f71\u54cd\uff0c\u8fd9\u4e9b\u8c03\u63a7\u7cfb\u7edf\u540c\u65f6\u6574\u5408\u4e86\u6d6e\u6e38\u7ec6\u83cc\u4e2a\u4f53\u7684\u72b6\u6001\u3001\u73af\u5883\u56e0\u7d20\u548c\u751f\u7269\u819c\u7fa4\u843d\u5185\u90e8\u7ec6\u83cc\u7684\u72b6\u6001\u3002\u76ee\u524d\uff0c\u6709\u5173Agr\u7fa4\u4f53\u5bc6\u5ea6\u611f\u5e94\u7cfb\u7edf\u7684\u7814\u7a76\u6700\u4e3a\u6210\u719f[26]\u3002\u7fa4\u4f53\u5bc6\u5ea6\u611f\u5e94\u7cfb\u7edf\u80fd\u591f\u4ea7\u751f\u81ea\u8bf1\u5bfc\u4fe1\u53f7\u5206\u5b50\u3002\u968f\u7740\u7ec6\u83cc\u7684\u805a\u96c6\uff0c\u4fe1\u53f7\u5206\u5b50\u5206\u6ccc\u589e\u591a\uff0c\u5f53\u8d85\u8fc7\u7cfb\u7edf\u611f\u53d7\u9608\u503c\u65f6\u5373\u53ef\u53d1\u6325\u57fa\u56e0\u8c03\u63a7\u4f5c\u7528\u3002\u4e00\u65b9\u9762\uff0cAgr\u7cfb\u7edf\u53ef\u901a\u8fc7\u6709\u6548\u8c03\u8282\u8bf8\u591a\u86cb\u767d\u9176\u548c\u915a\u53ef\u6eb6\u6027\u8c03\u8282\u86cb\u767dPSM\u7684\u4ea7\u751f\uff0c\u4ece\u800c\u8c03\u63a7\u91d1\u8461\u83cc\u751f\u7269\u819c\u7684\u6210\u719f\u548c\u5206\u89e3\uff1b\u53e6\u4e00\u65b9\u9762\uff0cAgr\u7cfb\u7edf\u53ef\u901a\u8fc7\u8bf1\u5bfc\u751f\u7269\u819c\u76f8\u5173\u57fa\u56e0(\u5982icaABDC\u64cd\u7eb5\u5b50)\u7684\u8868\u8fbe\uff0c\u4ece\u800c\u4fc3\u8fdb\u80de\u5916\u591a\u7cd6\u7b49\u751f\u7269\u819c\u57fa\u8d28\u6210\u5206\u7684\u8868\u8fbe\uff0c\u6700\u7ec8\u4fc3\u8fdb\u751f\u7269\u819c\u7684\u5f62\u6210[26]\u3002\u672c\u7814\u7a76\u53d1\u73b0\uff1a2 \u03bcg/mL\u7684CST\u4e0d\u4ec5\u80fd\u6291\u5236\u91d1\u8461\u83cc\u751f\u7269\u819c\u7684\u5f62\u6210\uff0c\u8fd8\u80fd\u663e\u8457\u5206\u6563\u5df2\u5f62\u6210\u7684\u751f\u7269\u819c\u3002\u7b14\u8005\u63a8\u6d4b\u5176\u6297\u751f\u7269\u819c\u7684\u673a\u5236\u53ef\u80fd\u6d89\u53ca\u751f\u7269\u819c\u5f62\u6210\u5468\u671f\u4e2d\u7684\u67d0\u4e2a\u73af\u8282\u6216Agr\u7fa4\u4f53\u5bc6\u5ea6\u611f\u5e94\u7cfb\u7edf\uff0c\u540e\u7eed\u8fd8\u6709\u5f85\u8fdb\u4e00\u6b65\u63a2\u7a76\u3002\n\u7efc\u4e0a\uff0cCST\u5bf9MRSA\u53ca\u5176\u4e34\u5e8a\u83cc\u682a\u5747\u5177\u6709\u5f3a\u6297\u83cc\u6d3b\u6027\uff0c\u5176MIC\u6781\u4f4e\uff0c\u4ec5\u4e3a0.125~1.000 \u03bcg/mL\u3002CST\u8fd8\u80fd\u6291\u5236MRSA\u751f\u7269\u819c\u7684\u5f62\u6210\uff0c\u5e76\u80fd\u6709\u6548\u6e05\u9664\u5df2\u5f62\u6210\u7684\u751f\u7269\u819c\u3002CST\u51e0\u4e4e\u4e0d\u4f1a\u51fa\u73b0\u91d1\u8461\u83cc\u8010\u836f\uff0c\u4e14\u7ec6\u80de\u6bd2\u6027\u6781\u4f4e\uff0c\u6210\u836f\u6f5c\u529b\u5927\u3002",
  "has_full_text": true
}